Eversana takes on predictive health analytics tech

By Jenni Spinner contact

- Last updated on GMT

(metamorworks/iStock via Getty Images Plus)
(metamorworks/iStock via Getty Images Plus)

Related tags: Data management, analytics, Pharmaceutical industry, development

With the acquisition of HVH Precision Analytics, the company has added new advanced analytics capabilities to its roster of life-sciences services.

Eversana has purchased HVH Precision Analytics, bringing on its analytics platform to the company’s offerings for the life-sciences industries. Originally designed for military and intelligence applications, the platform has been tailored for use in the healthcare sector.

Previously owned by Havas Health & You and Perspecta, HVH Precision Health appealed to Eversana because of its life-science experience and analytics capabilities, according to Brigham Hyde, president of Eversana’s Data and Analytics business unit.

“Their prediction-based platform is the most robust in the industry, and well known for its expertise in rare disease​,” Hyde told Outsourcing-Pharma. “It has the ability to bring together millions of data sources to provide tremendous insights to our clients and their patients on different conditions to ultimately help inform treatment options​.”

The ability to rapidly and effectively analyze health data collected from a variety of sources is important, Hyde added, especially as adoption of artificial intelligence (AI), machine learning (ML) and other advanced technologies becomes more widespread.

Most AI and ML platform solutions are disjointed from the services and interfaces that create meaningful impact for patients. By providing a prediction platform, built on integrated patient data, combined with our best-in-class patient engagement solutions, commercial services, market access, and distribution, we have the ability to make predictions and take actions within the same organization and deliver value to stakeholder​,” Hyde said.

According to Steve Costalas, CEO of HVH Precision Analytics, robust data and analytics technology are sorely needed in the pharmaceutical industry.

Our technology and talented team are at the forefront of the industry and are already propelling faster analysis and actions for EVERSANA clients. The fit is seamless, and we are onboarding new programs right now​,” he said.

HVH Precision Analytics reportedly will transition to the Eversana brand in the coming quarter, and the company’s leadership team will report to Hyde. Financial details of the transaction were not disclosed.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars